Key result
Within-domain cognitive intraindividual variability was higher in patients with mild cognitive impairment compared to healthy controls (p=0.05), suggesting its potential as a marker for prodromal Alzheimer's disease.
Cross-Sectional (n=206)
No
p-value: p=0.05
Within-domain intraindividual variability across cognitive control tasks may serve as a sensitive cognitive marker for detecting prodromal Alzheimer's disease at the mild cognitive impairment stage.
Within-domain IIV distinguished MCI from controls; leaves open its role as prodromal AD marker pending prospective validation.
Recent studies have shown that increased cognitive intraindividual variability (IIV) across accuracy scores from tests representing different cognitive domains (across-domain IIV) might indicate prodromal Alzheimer's disease (AD). Although IIV has been proposed to index cognitive control processes, IIV across accuracy scores from cognitive control tasks (within-domain IIV) has not been examined in healthy controls subjects (HCS), mild cognitive impairment (MCI), and AD patients in a single comparative study. This study examines the discriminative properties of within-domain IIV, and across-domain IIV in 149 HCS, 31 MCI, and 26 AD. Three tasks representing different cognitive domains were identified to calculate across-domain IIV. Three other tasks representing cognitive control were identified to calculate within-domain IIV. The intraindividual standard deviation was calculated across accuracy scores. To compare IIV between groups, ANCOVAs with the covariates age, gender, education, and mean performance were computed. IIV scores in general were higher in AD vs. HCS (p < 0.01). Only across-domain IIV was higher in AD vs. MCI (p = 0.001), and only within-domain IIV was higher in MCI vs. HCS (p = 0.05). Within-domain IIV may constitute a cognitive marker for the detection of prodromal AD at the MCI stage, whereas across-domain IIV may detect beginning AD at the MCI stage.
No takes yet. Share an insight, caveat, or question.
Kälin et al. (2014) conducted a cross-sectional in Prodromal Alzheimer's disease (n=206). Cognitive intraindividual variability (IIV) vs. Healthy control subjects was evaluated on Within-domain intraindividual variability (IIV) (p=0.05). Within-domain cognitive intraindividual variability was higher in patients with mild cognitive impairment compared to healthy controls (p=0.05), suggesting its potential as a marker for prodromal Alzheimer's disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: